BSX vs CLOV
Boston Scientific Corp (BSX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BSX and CLOV stock pages for the full models.
Not investment advice.